Free Trial
NYSE:MED

MEDIFAST (MED) Stock Price, News & Analysis

MEDIFAST logo
$13.50 -0.25 (-1.82%)
Closing price 03:59 PM Eastern
Extended Trading
$13.50 0.00 (-0.01%)
As of 06:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About MEDIFAST Stock (NYSE:MED)

Key Stats

Today's Range
$13.46
$13.85
50-Day Range
$12.48
$15.22
52-Week Range
$11.57
$21.98
Volume
145,054 shs
Average Volume
207,095 shs
Market Capitalization
$148.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.50
Consensus Rating
Hold

Company Overview

MEDIFAST Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
64th Percentile Overall Score

MED MarketRank™: 

MEDIFAST scored higher than 64% of companies evaluated by MarketBeat, and ranked 71st out of 150 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MEDIFAST has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    MEDIFAST has received no research coverage in the past 90 days.

  • Read more about MEDIFAST's stock forecast and price target.
  • Earnings Growth

    Earnings for MEDIFAST are expected to grow by 200.00% in the coming year, from $0.51 to $1.53 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MEDIFAST is -20.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MEDIFAST is -20.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MEDIFAST has a P/B Ratio of 0.70. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about MEDIFAST's valuation and earnings.
  • Percentage of Shares Shorted

    21.30% of the float of MEDIFAST has been sold short.
  • Short Interest Ratio / Days to Cover

    MEDIFAST has a short interest ratio ("days to cover") of 9.5.
  • Change versus previous month

    Short interest in MEDIFAST has recently increased by 18.62%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    MEDIFAST does not currently pay a dividend.

  • Dividend Growth

    MEDIFAST does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    21.30% of the float of MEDIFAST has been sold short.
  • Short Interest Ratio / Days to Cover

    MEDIFAST has a short interest ratio ("days to cover") of 9.5.
  • Change versus previous month

    Short interest in MEDIFAST has recently increased by 18.62%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for MEDIFAST this week, compared to 3 articles on an average week.
  • Search Interest

    3 people have searched for MED on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added MEDIFAST to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MEDIFAST insiders have bought more of their company's stock than they have sold. Specifically, they have bought $5,003.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 2.90% of the stock of MEDIFAST is held by insiders.

  • Percentage Held by Institutions

    95.51% of the stock of MEDIFAST is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MEDIFAST's insider trading history.
Receive MED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MEDIFAST and its competitors with MarketBeat's FREE daily newsletter.

MED Stock News Headlines

Medifast Announces Second Quarter 2025 Financial Results
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Medifast (MED) Projected to Post Earnings on Monday
Medifast Q2 2025 Earnings Preview
3 Unpopular Stocks We Keep Off Our Radar
See More Headlines

MED Stock Analysis - Frequently Asked Questions

MEDIFAST's stock was trading at $17.62 at the beginning of the year. Since then, MED shares have decreased by 23.4% and is now trading at $13.50.

MEDIFAST INC (NYSE:MED) released its quarterly earnings data on Monday, August, 4th. The specialty retailer reported $0.04 EPS for the quarter, beating analysts' consensus estimates of ($0.22) by $0.26. MEDIFAST had a negative net margin of 1.29% and a positive trailing twelve-month return on equity of 6.63%.
Read the conference call transcript
.

Top institutional investors of MEDIFAST include Peapod Lane Capital LLC (0.79%), SummerHaven Investment Management LLC (0.39%), Allianz Asset Management GmbH (0.20%) and Chickasaw Capital Management LLC (0.13%). Insiders that own company stock include Daniel R Chard, Scott Schlackman, Andrea B Thomas, Jeffrey J Brown and Constance J Hallquist.
View institutional ownership trends
.

Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MEDIFAST investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AU Optronics (AUOTY).

Company Calendar

Today
8/04/2025
Last Earnings
8/04/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
FOOD - MISC/DIVERSIFIED
Sub-Industry
Personal Products
Current Symbol
NYSE:MED
CIK
910329
Employees
870
Year Founded
N/A

Price Target and Rating

High Price Target
$16.50
Low Price Target
$16.50
Potential Upside/Downside
+22.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.65)
Trailing P/E Ratio
N/A
Forward P/E Ratio
26.47
P/E Growth
N/A
Net Income
$2.09 million
Net Margins
-1.29%
Pretax Margin
-1.34%
Return on Equity
6.63%
Return on Assets
4.81%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.52
Quick Ratio
2.87

Sales & Book Value

Annual Sales
$602.46 million
Price / Sales
0.25
Cash Flow
$2.88 per share
Price / Cash Flow
4.68
Book Value
$19.21 per share
Price / Book
0.70

Miscellaneous

Outstanding Shares
10,990,000
Free Float
10,672,000
Market Cap
$148.37 million
Optionable
Optionable
Beta
0.80

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NYSE:MED) was last updated on 8/4/2025 by MarketBeat.com Staff
From Our Partners